SF-6D health state utilities for lifestyle, sociodemographic and clinical characteristics of a large international cohort of people with multiple sclerosis

JA Campbell, GA Jelinek, TJ Weiland, N Nag… - Quality of Life …, 2020 - Springer
Background While many studies have examined the impacts of multiple sclerosis (MS) on
health-related quality of life (HRQoL), none have used the SF-6D multi-attribute utility …

A review of the psychometric properties of generic utility measures in multiple sclerosis

A Kuspinar, NE Mayo - Pharmacoeconomics, 2014 - Springer
Objective The reliability and validity of generic utility measures have not yet been
summarized in people with multiple sclerosis (MS). It is important to assess the psychometric …

Mapping the 12-item multiple sclerosis walking scale to the EuroQol 5-dimension index measure in North American multiple sclerosis patients

MF Sidovar, BL Limone, S Lee, CI Coleman - BMJ open, 2013 - bmjopen.bmj.com
Objective To map the 12-item Multiple Sclerosis Walking Scale (MSWS-12) onto the EuroQol
5-dimension (EQ-5D) health-utility index in multiple sclerosis (MS) patients participating in …

The effect of disease, functional status, and relapses on the utility of people with multiple sclerosis in the UK

M Orme, J Kerrigan, D Tyas, N Russell… - Value in health, 2007 - Wiley Online Library
Objectives: Because published utility estimates in multiple sclerosis (MS) are concentrated
in people with moderate to severe disease severity and focus on specific types of MS, we …

Using the Fatigue Severity Scale to inform healthcare decision-making in multiple sclerosis: mapping to three quality-adjusted life-year measures (EQ-5D-3L, SF-6D …

E Goodwin, A Hawton, C Green - Health and Quality of Life Outcomes, 2019 - Springer
Background Fatigue has a major influence on the quality of life of people with multiple
sclerosis. The Fatigue Severity Scale is a frequently used patient-reported measure of …

[HTML][HTML] Discordance in utility measurement in persons with neurological conditions: a comparison of the SF-6D and the HUI3

H Abel, G Kephart, T Packer, G Warner - Value in Health, 2017 - Elsevier
Objectives To examine the extent of disagreement in estimated utility between the six-
dimensional health state short form (SF-6D) and the Health Utilities Index—Mark 3 (HUI3) in …

Differences in utility scores obtained through Brazilian and UK value sets: a cross-sectional study

MLS Takemoto, N Lopes da Silva… - Health and quality of life …, 2015 - Springer
Background Multiple sclerosis (MS) is a chronic disease associated with several impacts;
especially regarding patients' health-related quality of life (HRQL). EuroQol 5 Dimensions …

Predictors of health utility in relapsing–remitting and secondary-progressive multiple sclerosis: implications for future economic models of disease-modifying therapies

L Hernandez, M O'Donnell, M Postma, MSOAC - PharmacoEconomics, 2021 - Springer
Background Decision-analytic models used in economic evaluations of disease-modifying
therapies for relapsing–remitting multiple sclerosis (RRMS) have characterized disease …

A scoring algorithm for deriving utility values from the Neuro-QoL for patients with multiple sclerosis

LS Matza, G Phillips, B Dewitt… - Medical Decision …, 2020 - journals.sagepub.com
Introduction The Neuro-QoL is a standardized approach to assessing health-related quality
of life in people with neurological conditions, including multiple sclerosis (MS). Item banks …

Measuring the health-related quality of life in Australians with multiple sclerosis using the assessment of quality of life-8-dimension (AQoL-8D) multi-attribute utility …

H Ahmad, I van der Mei, BV Taylor, JA Campbell… - Multiple Sclerosis and …, 2020 - Elsevier
Background Health-related quality of life (HRQoL) has not been assessed in Australians
with multiple sclerosis (MS) using a preferentially sensitive multi-attribute utility instrument …